The CDMO is building identical large-scale production facilities in the U.S. and Denmark, designed to modularly and seamlessly integrate manufacturing regardless of location.
Working with partner AstraZeneca, the French pharma giant has tripled production capacity and doubled the number of manufacturing sites since the launch of Beyfortus in 2023.
